Wordt geladen...
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Immunotherapy induces durable responses in a subset of patients with cancer. High TMB may be a response biomarker for PD-1/PD-L1 blockade in tumors such as melanoma and non-small cell lung cancer (NSCLC). Our aim was to examine the relationship between TMB and outcome in diverse cancers treated with...
Bewaard in:
| Gepubliceerd in: | Mol Cancer Ther |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5670009/ https://ncbi.nlm.nih.gov/pubmed/28835386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-17-0386 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|